Effect of the Secretary of Health and Human Services' Failure to Make the Demonstration Required by the Medicine and Drug Safety Act of 2000 On Any Possible Future Implementation of the Act.
Examines language and structure of provisions of P.L. 106-387, the Medicine Equity and Drug Safety Act of 2000, which permit reimportation of prescription drugs from foreign countries pursuant to regulations promulgated by the Secretary of HHS, in light of current Secretary's inability to trigg...
| Corporate Authors: | , |
|---|---|
| Format: | eBook |
| Language: | English |
| Published: |
[Place of publication not identified] :
[publisher not identified],
2001.
|
| Series: | U.S. Congressional Research.
|
| Subjects: | |
| Online Access: | Connect to the full text of this electronic book |
| Summary: | Examines language and structure of provisions of P.L. 106-387, the Medicine Equity and Drug Safety Act of 2000, which permit reimportation of prescription drugs from foreign countries pursuant to regulations promulgated by the Secretary of HHS, in light of current Secretary's inability to trigger regulatory implementation procedures. |
|---|---|
| Item Description: | Record is based on bibliographic data in ProQuest U.S. Congressional Research Digital Collection (last viewed July 2010). Reuse except for individual research requires license from ProQuest, LLC. CRS Report. Electronic resource. |
| Physical Description: | 1 online resource. |